MOB: +46707742137
Medical researchers are making significant strides in patient care through the development of digital twins—virtual replicas of patients that allow for the simulation of various treatment options without risking the individual’s health. Mikael Benson, a prominent researcher at Karolinska Institutet, believes that in the future, these digital twins could become commonplace, enabling personalized treatment plans tailored to each individual.
Traditionally, healthcare providers face the challenge of determining the most effective treatment for patients. Often, this involves trial and error with various medications, leading to extended wait times and increased costs. In some cases, the delay in finding an effective treatment can have serious consequences for patient health, including the potential for life-threatening situations. The innovative approach of using digital twins aims to change this paradigm by allowing healthcare professionals to simulate treatments on a computer before applying them to real patients.
Benson describes digital twins as virtual test subjects designed to closely mimic the biological processes of individual patients. This technology enables simultaneous testing of multiple treatments, rather than evaluating them one by one. In his view, the potential for immediate feedback on treatment efficacy could significantly enhance patient outcomes.
“Most diseases are extremely complex,” Benson explains. “The same treatment can yield different results for different people due to variations in genetic makeup and cellular activity.” He estimates that approximately 50% of all prescribed treatments are ineffective, emphasizing the need for more efficient methods of determining suitable therapies.
Recent studies conducted by Benson’s team have demonstrated promising results. They tested digital twins on mice with rheumatoid arthritis and on patients with Crohn’s disease, finding that the outcomes of the simulations aligned closely with real-world results. Additionally, the research group published a study in the scientific journal Cancer Research, refining methods for the early diagnosis of prostate cancer. Currently, they are preparing to investigate how digital twins might assist in preventing cancer in patients with ulcerative colitis.
As the research progresses, the focus will shift towards serious diseases that involve costly treatments, such as cancer and inflammatory bowel disease. Benson indicates that early diagnosis and effective treatment strategies will be central to future applications of digital twin technology.
To facilitate these medical simulations, a comprehensive database of patient-specific biological information is essential. The digital twin model requires data on cellular activities, genetics, symptoms, and results from routine clinical examinations, such as X-rays. By employing single-cell analysis, researchers gather detailed insights into the patient’s condition. This information is then analyzed with the aid of machine learning to identify patterns that characterize the disease for each individual.
The broader trend of using computer simulations in various fields has made digital twins a vital tool in healthcare. While Benson’s digital twins are primarily mathematical models, other researchers are exploring designs that visually resemble patients. Such models could enhance discussions between doctors and patients, making treatment options more tangible and understandable.
Despite the advancements, Benson cautions against the uncritical adoption of digital twins in healthcare. The increased knowledge they provide may lead to psychological stress, particularly concerning lifestyle factors like diet and exercise. “The importance of the choices a patient makes becomes clear, which may lead to feelings of guilt or pressure,” he notes.
Looking ahead, Benson envisions a future where every individual has access to their own digital twin from a young age, guiding them throughout their lives. This personalized approach to healthcare could transform how treatments are developed and administered, paving the way for improved health outcomes.
